Wistar's Jessie Villanueva, Ph.D., Receives 'Diversity in Business' Award
Jessie Villanueva, Ph.D., is one of the recipients of the 2024 Diversity in Business Award from the Philadelphia Business Journal.
Source: newswise.com
Cellular Oncogenesis Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cellular Oncogenesis Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cellular Oncogenesis Program Today - Breaking & Trending Today
Wistar's Jessie Villanueva, Ph.D., Receives 'Diversity in Business' Award
Jessie Villanueva, Ph.D., is one of the recipients of the 2024 Diversity in Business Award from the Philadelphia Business Journal.
Source: newswise.com
Wistar Researchers Discover Possible New Treatment for
PHILADELPHIA, PA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the...
Source: globenewswire.com
Research demonstrates a double-acting mechanism for fighting triple-negative breast cancer
Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has published a new paper in the journal Nature Cancer.
Source: news-medical.net
Wistar researchers discover possible new trea
Zachary Schug, Ph.D., assistant professor at The Wistar Institute, has published a new paper in the journal Nature Cancer demonstrates a double-acting mechanism for fighting a particularly aggressive, difficult-to-treat form of breast cancer. Schug’s research shows how silencing a certain gene, ACSS2, may improve existing treatments for patients.
Source: eurekalert.org